: Of the 113 randomized patients , 110 ( 70 CrPic , 40 placebo ) constituted the intent-to-treat ( ITT ) population ( i.e. , received at least one dose of study medication and completed at least one efficacy evaluation ) and 75 ( 50 CrPic , 25 placebo ) were evaluable ( i.e. , took at least 80 % of study drug with no significant protocol deviations ) .
